MY135649A - Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders - Google Patents

Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders

Info

Publication number
MY135649A
MY135649A MYPI20032853A MY135649A MY 135649 A MY135649 A MY 135649A MY PI20032853 A MYPI20032853 A MY PI20032853A MY 135649 A MY135649 A MY 135649A
Authority
MY
Malaysia
Prior art keywords
hyper
treatment
benzofuran
proliferative disorders
derivatives useful
Prior art date
Application number
Inventor
Chengzhi Zhang
Wendy Lee
Barton Phillips
Michael Burke
Zhi Chen
Jacques Dumas
Dongping Fan
Jianmei Fan
Holia Hatoum-Mokdad
Benjamin D Jones
Geatan Ladouceur
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of MY135649A publication Critical patent/MY135649A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

THIS INVENTION RELATES TO NOVEL BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES OF THE GENERAL FORMULAAND THEIR USE FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS.
MYPI20032853 2002-07-31 2003-07-29 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders MY135649A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39988602P 2002-07-31 2002-07-31

Publications (1)

Publication Number Publication Date
MY135649A true MY135649A (en) 2008-06-30

Family

ID=38812802

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20032853 MY135649A (en) 2002-07-31 2003-07-29 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders

Country Status (7)

Country Link
AR (1) AR040669A1 (en)
GT (1) GT200300158A (en)
HN (1) HN2003000228A (en)
MY (1) MY135649A (en)
PE (1) PE20040723A1 (en)
TW (1) TW200413343A (en)
UY (1) UY27916A1 (en)

Also Published As

Publication number Publication date
PE20040723A1 (en) 2004-10-29
UY27916A1 (en) 2003-12-31
TW200413343A (en) 2004-08-01
GT200300158A (en) 2004-06-08
AR040669A1 (en) 2005-04-13
HN2003000228A (en) 2004-08-02

Similar Documents

Publication Publication Date Title
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
TW200510416A (en) P38 inhibitors and methods of use thereof
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
GB0222495D0 (en) Compounds
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
CY1112238T1 (en) ANTI-KINESIN SUSPENSIONS AND METHODS OF USING THESE
PL1646634T3 (en) Use of rapamycin and rapamycin derivatives for the treatment of bone loss
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
NO20034056D0 (en) Proliferative diseases
MXPA06000123A (en) Use of rapamycin and rapamycin derivatives for the treatment of bone loss.
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
MY137053A (en) Pyrimidine derivatives and their use as cb2 modulators
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
AU2003220300A1 (en) Compositions useful as inhibitors of protein kinases
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
MXPA05008438A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands.
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20055563L (en) Means for the treatment of lower abdominal disorders
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
MXPA03007653A (en) Use of lp82 to treat hematopoietic disorders.
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
EG24959A (en) Indoles useful in the treatment of androgenreceptor related diseases.
TW200503717A (en) Substituted 1,4-pyrazine derivatives
DE602004019541D1 (en) CYCLOALKYLÄBÜ CONDENSED INDOLE